What happened in optometry this week: February 19 - February 23

Blog
Article

Catch up on what happened in optometry during the week of February 19-February 23.

Catch up with what Optometry Times shared this week:

Consensus guidelines on GA diagnosis and management

By Lynda Charters and Carl R. Regillo, MD

With the current focus on stopping the progression to geographic atrophy (GA) associated with age-related macular degeneration (AMD), physicians and researchers are fine-tuning the identification of the various disease stages, management scenarios, and treatment considerations for this patient population.

Read here...

IKA Keratoconus Symposium to bring "best of the best"

By Emily Kaiser Maharjan, Assistant Managing Editor, Andrew S. Morgenstern, OD, FAAO, FNAP, and Jordana Joy, Associate Editor

This spring, there is more to look forward to than just warmer weather. The International Keratoconus Academy (IKA) is holding its second annual Keratoconus Symposium, running from May 18 and 19 in Bethesda, Maryland. IKA President and Cofounder Andrew S. Morgenstern, OD, FAAO, FNAP sat down with Optometry Times to detail what's to come at this year's event, as well as shed light on keratoconus and technological advancements to aid in treatments and diagnosis.

Read here...

Current management and prevention of vitreoretinal complications of high myopia

By Lynda Charters and Cassie A. Ludwig, MD, MSc

Cassie A. Ludwig, MD, MSc, Assistant Professor of Ophthalmology, Stanford University, Stanford, CA, addressed the epidemic of myopia and its vitreoretinal complications at the Envision Summit in Puerto Rico.

Read here...

A new era of assistive technology for patients with low vision

By Jason E. Vice, PhD, OT, SCLV

As an occupational therapist working in low vision rehabilitation, I collaborate with a multidisciplinary team to provide the highest level of service possible to patients with visual impairments. Individuals of all ages can experience vision loss due to a variety of conditions—from eye disease to acquired brain injury. Our aim is to help patients maximize their remaining vision so they may participate as fully as possible in activities that are important to them.

Read here...

The importance of early referral and awareness regarding AMD, low vision

By Jordana Joy, Associate Editor and Tracy Williams, OD, FAAO

In honor of Age-related Macular Degeneration (AMD) Awareness Month, Optometry Times sat down with R Tracy Williams, OD, FAAO, to chat about the significance of referring patients early for AMD concerns and the role that awareness plays in slowing the progression of low vision.

Read here...

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.